ArticleJournal of animal science2026
Sixty-day oral antioxidant supplementation enhances sperm morphology and seminal plasma antioxidant capacity in stallions.
Article in Journal of animal science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
While dietary supplementation with antioxidants has been identified as an effective strategy for mitigating oxidative stress (OS) damage in stallion sperm, specific protocols and the duration of its efficacy remain poorly defined. This study aimed to evaluate the effects of a 60-d dietary supplementation with a commercial antioxidant combination on semen quality and OS biomarkers in stallions. Stallions were divided into two groups: the control group (n = 5; CTRL) received 30 g/500 kg of placebo while the treated group (n = 5; OXY) received 30 g/500 kg of Oxyliver daily for 60 d. Semen was evaluated for volume, concentration, viability, morphology, membrane integrity, motility, and kinetic parameters every 15 d for the 60-d supplementation period and for an additional 60 d after treatment cessation (D0, D15, D30, D45, D60, DP15, DP30, DP45, DP60). Total antioxidant capacity (TAC), ferric reducing/antioxidant power (FRAP), and malondialdehyde (MDA) were measured at 30-d intervals. The change in sperm parameters over time differed significantly between groups, specifically for sperm membrane integrity (P = 0.004), total motility (P = 0.003), morphological abnormalities (P = 0.028), and OS parameters (TAC P = 0.031, FRAP P = 0.044, MDA P = 0.048). Compared to CTRL, the OXY group showed greater sperm membrane integrity (P = 0.004) and total motility (P = 0.039) at D60. Conversely, total morphological abnormalities were lower in OXY at D60 (P = 0.003), DP15 (P = 0.009), and DP30 (P = 0.018), mainly due to a reduction in tail defects at the same time points (P = 0.008, P = 0.014, P = 0.020, respectively). Moreover, TAC and FRAP were greater in the OXY group at D30 (P = 0.004 and P = 0.012, respectively) and D60 (P = 0.001 and P = 0.009, respectively), while MDA concentrations were lower in the OXY group at D60 (P < 0.001), DP30 (P = 0.033) and DP60 (P = 0.003). In conclusion, despite the small sample size, this longitudinal study provides preliminary evidence that a 60-d supplementation with this combined formula enhances seminal plasma antioxidant capacity during supplementation and reduces lipid peroxidation even after the end of supplementation. It also induces a transient improvement in sperm membrane functionality and total motility at specific time points, whereas sperm morphology showed a more robust improvement beyond the supplementation period.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.